AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05531396 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Health Education
Description: Participants in the control group will receive health educational guidelines. Guideline contents include home-based exercise program, nutrition recommendations, and fall prevention education. The home-based exercise program will emphasize how to safely and properly perform stretching and whole-body exercises.
Study NCT05713318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HH-120 nasal spray
Description: Nasal spray daily doses of HH-120 4 times added on SOC for 6 consecutive days.
Study NCT05713318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HH-120 nasal spray
Description: Nasal spray daily doses of HH-120 8 times added on SOC for 6 consecutive days.
Study NCT05713318 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Nasal spray daily doses of placebo 4 times added on SOC for 6 consecutive days.
Study NCT05713318 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Nasal spray daily doses of placebo 8 times added on SOC for 6 consecutive days.
Study NCT05256914 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ozoral Pro and Ozoral gel administration
Description: Peri-implant mucositis sites will receive in-office Ozoral Pro administration after non-surgical therapy. Patients will use Ozoral Gel for the domiciliary administration once a day for 14 days after the visits (no rinsing and eating for 30 minutes after gel application).
Study NCT05256914 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Curasept chlorhexidine gel 1%
Description: Peri-implant mucositis sites will receive in-office Curasept chlorhexidine gel 1% administration after non-surgical therapy. Patients will use chlorhexidine gel 1% for the domiciliary application once a day for 14 days after the visits (no rinsing and eating for 30 minutes after gel application).
Study NCT05128539 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS001(Toripalimab)+JS002
Description: Part A: In this phase, 3 dose levels will be preliminarily set up. The dose level of Toripalimab is fixed as 240 mg, intravenous infusion, Q3W. The dose levels of JS002 are fixed at 75 mg,150 mg and 300 mg subcutaneously, and the traditional 3+3 design will be used for dose escalation with 21 days as entire treatment cycle. In addition, the period of 21 days after the first administration is defined as the DLT observation period.~Part B: Based on the data of the safety, PK and preliminary efficacy in Part A patients, the dosage will be determined for advanced tumor patients who had received at least first-line therapy in this part. Two to three groups with different tumor types will be further enrolled, and about 30 patients will be included in each group (the specific number and cohort will be adjusted according to the research progress). Toripalimab is a humanized IgG4κ mAb specific against human PD-1.
Study NCT06379451 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKG2D Chimeric Antigen Receptor NK Cell Injection
Description: Administer KN1102 cell injection three times on day 0, day 7, and day 14, respectively.
Study NCT04827602 — intervention group
Intervention type: OTHER
Intervention: Drug allergy label status in electronic health records
Description: Registered drug allergy labels in primary care and hospital electronic medical charts
Study NCT06170931 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: posterior cruciate ligament-retaining prostheses
Description: Posterior cruciate ligament protective approach in patients with knee osteoarthritis
Study NCT06170931 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: posterior cruciate ligament-substituting prostheses
Description: Posterior cruciate ligament transection approach in patients with knee osteoarthritis
Study NCT05476978 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EUS-AI model
Description: The test subset (approximately 20% of total patients) is reserved for the final evaluation of the EUS-AI model. Clinical parameters and EUS pictures of each patient in the test subset will be inputed into the trained EUS-AI model, and the most possible diagnosis will be given by the model.
Study NCT06345924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MERAKI_PC
Description: The three music therapy sessions focus on helping the patient to adjust to their situation. The aim is to provide emotional support and encourage communication between family members through music. In addition, the therapy will help the patient to appreciate their remaining abilities and encourage their involvement in the rehabilitation process. The second session focuses on living in the present through re-identification. The session aims to improve the symptoms associated with the illness by focusing on the present situation and encouraging expression.~The main aim of the final session, 'The Journey of Life - Leaving a Mark', is to recapitulate and provide support.~Songs are used during the session, taking into account musical preferences.
Study NCT06024928 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control-IQ use in Type 2 Diabetes under basal insulin injections
Description: Testing the safety and feasibility of using Automated Insulin Delivery (AID) in people with Type 2 Diabetes under basal insulin injections to achieve safe and fast basal insulin titration.
Study NCT06353035 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rewilding
Description: Private yards of the intervention study subjects will be modified with vegetation and deadwood.
Study NCT05238285 — intervention group
Intervention type: BEHAVIORAL
Intervention: Production of vocal sounds
Description: Participants will be asked to produce vocal sounds of different nature according to the non-verbal parameters of interest for the given study.~For example, they can read a script containing vowels ('a', 'e', 'i', 'o', 'u'), short sentences ('hello, how are you'), longer passages of standardised reading texts, and can also be asked to speak freely about any topic ('freedom of speech'). They can be asked to play a role or to imitate a particular emotional state. For example, imagine that you have just been told that you have won a million euros in the lottery. Produce a vocalisation to express your excitement or talk to your dog your dog by imagining that he has done a negative action and then do the same thing by imagining that this time imagining that the action was positive.
Study NCT06195150 — intervention group
Intervention type: OTHER
Intervention: Blood collection
Description: 15ml of blood are harvested before surgery
Study NCT05935982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual reality exercise
Description: During school special physical education, participants will be asked to exercise using a virtual reality exercise headset, that will be adapted for arm use. Participants will asked to be seated during gameplay. Heart rate will be monitored and recorded during exercise.
Study NCT06283381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Description: oral administration, tablets, 40 mg
Study NCT06283381 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole
Description: oral administration, tablets, 40 mg
Study NCT06134310 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fascial Distortion Model
Description: The following techniques were used on the cranial and cervical areas during therapy: Trigger band technique, herniated trigger point technique, continuum technique, folding technique, cylinder technique, and tectonic technique.
Study NCT06134310 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Core Stabilization Training
Description: Week 1st (1 x 10 reps): Supine deep cervical activation, supine deep lumbar activation, prone deep cervical activation, prone deep lumbar activation, supine combined deep cervical and lumbar activation, and prone combined deep cervical and lumbar activation; Week 2nd (1 x 10 reps): Arm openings, hundreds 1, one leg stretch 1, double leg stretch 1, shoulder bridge, breaststroke, leg pull prone prep 1; Week 3rd (1 x 10 reps): Arm openings, hundreds 2, one leg stretch 2, double leg stretch 2, shoulder bridge, breaststroke, leg pull prone prep 2; Week 4th (1 x 10 reps): Arm openings, hundreds 2, one leg stretch 2, double leg stretch 3, shoulder bridge, breaststroke, leg pull prone prep 2; Week 5th to 8th (with Resistance Band; 1 x 10 reps): Arm openings, shoulder bridge, swan dive, scapula isolations, plough, biceps curl, roll up, roll up with biceps, roll up with rowing, seated spine twist, swimming in kneeling, one leg kick in kneeling and diamond press in standing
Study NCT06134310 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rocabado's 6x6 Exercises
Description: Resting position of the tongue, rotational control of temporomandibular joint, rhythmic stabilization, axial extension of the neck, shoulder posture, and stabilized head flexion
Study NCT06574867 — intervention group
Intervention type: DEVICE
Intervention: viQtor Wearable Monitoring Device
Description: The viQtor device is a wearable medical device designed for continuous monitoring of vital signs, including heart rate (PR), respiratory rate (RR), and blood oxygen saturation (SpO2). It is worn on the upper arm and transmits data wirelessly to a cloud-based platform. This device is being evaluated as part of the standard monitoring protocol for post-operative patients in a surgical ward setting.
Study NCT06134310 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Education
Description: Participants are instructed to perform some behaviors while avoiding others based on the etiology of temporomandibular disorders.
Study NCT05639569 — intervention group
Intervention type: DEVICE
Intervention: Ankura™ TAA Stent Graft System
Description: All patients will be implanted with Ankura™ TAA Stent Graft System in accordance with the instructions for use (IFU).
Study NCT05941507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LCB84
Description: TROP2-directed human monoclonal antibody (Ab) linked to a monomethyl auristatin E (MMAE) prodrug
Study NCT05941507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 monoclonal antibody
Description: anti-PD-1 Ab
Study NCT05790681 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin icodec
Description: Participants will receive subcutaneously fixed dose of insulin icodec (700 U/mL) that is 5.6 U/kg bodyweight.
Study NCT05655364 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile application
Description: Breastfeeding Supportive Mobile Application
Study NCT05427331 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FMT capsule
Description: Patients with insomnia need to take FMT capsules orally in an empty stomach in the morning, 16 capsules once a week, for 4 consecutive weeks
Study NCT05427331 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: FMT capsule
Description: Patients with insomnia need to take FMT capsules orally in an empty stomach in the morning, 16 capsules once a week, for 4 consecutive weeks
Study NCT04762745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle, 1cycle.
Study NCT04762745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine( Leweixin®, Chia Tai TIANQING, China), 60mg/m2/d, intravenously(IV), d1-2, 28d/cycle, 1 cycle.
Study NCT04762745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle, 1 cycle.
Study NCT04762745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine( Leweixin®, Chia Tai TIANQING, China), 70mg/m2/d, intravenously(IV), d1-2, 28d/cycle, 1 cycle.
Study NCT04762745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle, 8 cycles. Then pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle until progression or intolerable toxicities.
Study NCT04762745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine( Leweixin®, Chia Tai TIANQING, China), 70mg/m2/d, intravenously(IV), d1-2, 28d/cycle, 8 cycles.
Study NCT04762745 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle, 8 cycles. Then dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle until progression or intolerable toxicities.
Study NCT04841057 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 50 cm BP limb length
Description: 50 cm biliopancreatic limb length
Study NCT04841057 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 100 cm BP limb length
Description: 100 cm biliopancreatic limb length
Study NCT05791305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: double duty intervention packages
Description: The intervention employed in this study will serve as double-duty interventions. The WHO policy short report from 2017 and Hawkes et al2020 .'s were amended and used as the basis for the DDIs packages. The main components of the intervention packages are the promotion of a minimum level of dietary diversity, avoiding unwarranted harm from high-energy foods, and controlling market foods from the perspective of the consumer. The following central criteria will be used to evaluate the study's intervention packages.
Study NCT06647355 — intervention group
Intervention type: OTHER
Intervention: Effectiveness of physical exercise in preventing pain and improving plantar pressure distribution
Description: At the beginning of the study, the participants underwent a baropodometric and photometric analysis. At the same time, anthropometric data and self-assessed body pain data were collected. For 12 continuous weeks, the participants completed a training programme that included specific exercises designed for each group. At the end, the baropodometry images were analysed again, which led to the final conclusion of the study.
Study NCT04841057 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 150 cm BP limb length
Description: 150 cm BP limb length
Study NCT05108337 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block
Description: Ultrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml 0.5% ropinacaine.
Study NCT05108337 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: Ultrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml normal saline.
Study NCT05904847 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Application of The Theory of Planned Behaviour for Diabetes
Description: In the study, diabetes education consisting of a total of 4 sessions structured according to the Planned Behavior Theory will be applied to the intervention group, and a standard diabetes education consisting of a single session containing information about diabetes on the website of the Ministry of Health will be applied to the control group. The training will be given face-to-face in groups of 10-15 people. After the training, the participants will be monitored for 3 months. To increase patient empowerment and self-efficacy, the intervention group will be followed up by phone calls every 15 days to increase motivation and answer questions.
Study NCT06299397 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: breastfeeding - humor training
Description: Breastfeeding and humor-based practice will continue for 35-45 minutes, once a week for 2 weeks.
Study NCT06299397 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control Group
Description: After randomization, consent was obtained from the pregnant women determined that they agreed to participate in the study. The pregnant women in the control group were given a pre-test before starting the study, an interim test 1 month after the start, and a final test 3 months later.
Study NCT05487872 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mindfulness skills training to reduce experiential avoidance and anxiety symptoms
Description: The intervention aimed to increase participants' mindfulness skills which may be critical in decreasing general experiential avoidance and anxiety symptoms
Study NCT06489613 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: M protein detection by iMS-LC Assay
Description: iMS-LC Assay (intact M-protein Screening-Light Chain Assay) technology is a new method for the specific identification of M-proteins in peripheral blood, based on mass spectrometry recognition of intact clonal immunoglobulin light chains. Combined with AI algorithm models, M-proteins can be easily distinguished from the polyclonal background, enabling automated identification and quantitative analysis of M-proteins.~Previous studies have shown that the detection limit of the iMS-LC Assay is several times higher than that of IFE. Additionally, the iMS-LC Assay requires only 5 μL of peripheral blood serum for detection, offering advantages over traditional methods in terms of higher sensitivity, non-invasiveness, lower sample volume requirements, reduced detection costs, and higher throughput.
Study NCT05978765 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dry Cupping
Description: treated by using dynamic cupping. Heating pad will be applied for 10 minutes as a base treatment then olive oil or petroleum jelly will be applied and a cup will be placed, a vacuum will be created by using vacuum pump then the cup will be moved to and fro or in figure of 8 for 5 minutes.
Study NCT05978765 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release
Description: e treated by soft tissue myofascial release. Heating pad will be applied for 10 minutes as a base treatment,petroleum jelly will be applied to the area follow by soft tissue myofascial release technique for 5 minutes either criss cross, along the fiber or in figure of 8
Study NCT04894253 — intervention group
Intervention type: BIOLOGICAL
Intervention: SRAS-CoV-2 vaccination immunological response
Description: Follow for 18 months a single group of 30 patients with systemic lupus after their SRAS-CoV-2 vaccination.~Intervention includes immunological analysis on additional volume of blood collected as part of routine care.
Study NCT05518929 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol
Description: The sedation of gastrointestinal endoscopy with Ciprofol
Study NCT05518929 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: The sedation of gastrointestinal endoscopy with Propofol
Study NCT06486753 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chevron osteotomy bunion surgery with lateral soft tissue release
Description: Lateral soft tissue release is often performed in hallux valgus correction, and there is preliminary evidence to suggest it may be useful in improving post-surgical outcomes for the Chevron osteotomy bunion surgery.
Study NCT05934734 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is an observational cross-sectional study. No intervention will be provided. Participants will be assessed and stratified into four cohorts based on self-reported symptom severity of thoracic outlet syndrome using a visual analog scale (VAS) to investigate the relationship between symptom severity and upper extremity function/neural integrity.
Study NCT04782596 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Posterium nasal septum resection
Description: Posterium nasal septum resection is required to ensure approach during transnasal endoscopic pituitary surgery in patients with pituitary adenoma.
Study NCT05487872 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness skills training to reduce experiential avoidance and anxiety symptoms
Description: The intervention aimed to increase participants' mindfulness skills which may be critical in decreasing general experiential avoidance and anxiety symptoms
Study NCT05588830 — intervention group
Intervention type: DRUG
Intervention: Belimumab
Description: Belimumab, 10mg/kg, was administered intravenously on the 0, 14 and 28 days, and then once every 28 days until the 24th week
Study NCT05588830 — intervention group
Intervention type: DRUG
Intervention: Telitacicept
Description: Telitacicept is injected subcutaneously, 160mg/time, once a week, for a total of 24 weeks
Study NCT04454970 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Urethrotech Urethral catheterisation device (UCD)
Description: Urethral indwelling catheter
Study NCT04454970 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bardia Aquafil long term catheter
Description: Urethral indwelling catheter
Study NCT06314984 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group I A (Conventional needle syringe)
Description: The injection site was isolated using cotton roll and the topical anesthesia (Benzocaine 4%) was applied to the injection site and left for 3-5 minutes then the injection was done in the mandible by the conventional needle syringe \[Inferior Alveolar Nerve Block\].
Study NCT06314984 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group I B (Conventional needle syringe)
Description: The injection site was isolated using cotton roll and the topical anesthesia (Benzocaine 4%) was applied to the injection site and left for 3-5 minutes then the injection was done in the maxilla by the conventional needle syringe \[Infiltration\].
Study NCT06314984 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group II A (Comfort-in Jet Injector)
Description: The injection site was isolated using a cotton roll and the topical anesthesia (Benzocaine 4%) was applied to the injection site and left for 3-5 minutes then the injection was done in the mandible by the needleless Comfort-in jet injector \[Inferior Alveolar Nerve Block\].